Onconova Therapeutics
ONTX
$1.00
Share price
-0.47%
Change (1 day)
-11.92%
Change (1 year)
Categories
Onconova Therapeutics (ONTX) - Cash on Hand
Cash on Hand as of September 2023 : $25.24 M
According to Onconova Therapeutics's latest financial reports the company has $25.24 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Onconova Therapeutics - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $38.75 M | -29.62% |
| 2021-12-31 | $55.07 M | 189.46% |
| 2020-12-31 | $19.02 M | -16.29% |
| 2019-12-31 | $22.72 M | 33.92% |
| 2018-12-31 | $16.97 M | 321.72% |
| 2017-12-31 | $4.02 M | -81.24% |
| 2016-12-31 | $21.45 M | 8.34% |
| 2015-12-31 | $19.79 M | -54.57% |
| 2014-12-31 | $43.58 M | -56.42% |
| 2013-12-31 | $0.10 B | 22.66% |
| 2012-12-31 | $81.52 M | 2905.05% |
| 2011-12-31 | $2.71 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Baxter BAX | $3.19 B | 12,552.51% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | $56.13 M | 122.37% | 🇺🇸 USA |
 CTI BioPharma
CTIC | $59.01 M | 133.76% | 🇺🇸 USA |
 Cleveland BioLabs
CBLI | N/A | N/A | 🇺🇸 USA |
 Array Technologies ARRY | $0.24 B | 886.69% | 🇺🇸 USA |